Laman UtamaAIM • NYSEAMERICAN
add
AIM ImmunoTech Inc
$0.21
Selepas Waktu Dagangan:(1.62%)+0.0034
$0.21
Tutup: 22 Nov, 7:55:47 PTG GMT-5 · USD · NYSEAMERICAN · Penafian
Tutup sebelumnya
$0.21
Julat hari
$0.21 - $0.22
Julat tahun
$0.16 - $0.62
Permodalan pasaran
13.49J USD
Bilangan Purata
531.02K
Nisbah P/E
-
Hasil dividen
-
Dalam berita
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Sep 2024info | Perubahan T/T |
|---|---|---|
Hasil | 35.00K | -23.91% |
Perbelanjaan pengendalian | 4.52J | -44.74% |
Pendapatan bersih | -3.70J | 52.66% |
Margin untung bersih | -10.57K | 37.78% |
Pendapatan bagi setiap syer | -0.07 | 57.39% |
EBITDA | -4.43J | 45.38% |
Kadar cukai berkesan | — | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Sep 2024info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 7.20J | -67.89% |
Jumlah aset | 13.59J | -51.23% |
Jumlah liabiliti | 10.68J | 103.00% |
Jumlah ekuiti | 2.91J | — |
Syer tertunggak | 63.71J | — |
Harga kepada buku | 4.23 | — |
Pulangan pada aset | -76.60% | — |
Pulangan pada modal | -142.29% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Sep 2024info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | -3.70J | 52.66% |
Tunai daripada operasi | -3.11J | 45.16% |
Tunai daripada pelaburan | 334.00K | 199.40% |
Tunai daripada pembiayaan | 137.00K | -41.20% |
Perubahan bersih dalam tunai | -2.64J | 54.30% |
Aliran tunai bebas | -2.11J | 34.80% |
Perihal
AIM ImmunoTech Inc., formerly known as Hemispherx Biopharma Inc., is a biopharmaceutical company based in Ocala, Florida that is focused on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Founded in 1990, the company has twenty-three employees.
The company has created an immunomodulatory double stranded RNA drug called Ampligen.
It is also developing Ampligen to use as a treatment for multiple cancer tumor types, COVID-19 and chronic fatigue syndrome. Wikipedia
Diasaskan
1966
Ibu pejabat
Tapak web
Pekerja
27
